Nektar Therapeutics SEC filings NKTR

Nektar Therapeutics has 1,000 filings in SEC EDGAR's recent list, going back to Aug 5, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Nektar Therapeutics SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Oct 20, 2026 —
8-K Current report
Regulation FD disclosure
Oct 1, 2026 Oct 1, 2026
8-K Current report
Other events
Sep 25, 2026 Sep 24, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
S-8 Employee stock plan registration Aug 14, 2026 —
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 5, 2026
424B5 Prospectus supplement May 8, 2026 —
8-K Current report
Material agreement, Officer or director change
May 8, 2026 May 8, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 4, 2026
8-K Current report
Material agreement, Other events
Apr 23, 2026 Apr 21, 2026
424B5 Prospectus supplement Apr 23, 2026 —
424B5 Prospectus supplement Apr 20, 2026 —
8-K Current report
Regulation FD disclosure
Apr 20, 2026 Apr 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 20, 2026 Apr 20, 2026
10-K Annual report Mar 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Material agreement, Other events
Feb 13, 2026 Feb 11, 2026
424B5 Prospectus supplement Feb 13, 2026 —
424B5 Prospectus supplement Feb 10, 2026 —
8-K Current report
Regulation FD disclosure
Feb 10, 2026 Feb 10, 2026
8-K Current report
Regulation FD disclosure, Other events
Feb 10, 2026 Feb 10, 2026
8-K Current report
Regulation FD disclosure
Jan 27, 2026 Jan 27, 2026
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2025 Dec 16, 2025
8-K Current report
Officer or director change
Nov 21, 2025 Nov 21, 2025
S-8 Employee stock plan registration Nov 12, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
S-3ASR Automatic shelf registration Nov 12, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 8, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2025 Sep 18, 2025
S-8 Employee stock plan registration Aug 8, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Material agreement, Other events
Jul 1, 2025 Jun 30, 2025
424B5 Prospectus supplement Jul 1, 2025 —
424B5 Prospectus supplement Jun 30, 2025 —
8-K Current report
Other events
Jun 27, 2025 Jun 24, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Bylaw or fiscal year change
Jun 6, 2025 Jun 6, 2025
8-K Current report
Other events
Jun 4, 2025 Jun 4, 2025
8-K Current report
Shareholder vote results
May 28, 2025 May 23, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 25, 2025 May 23, 2025
PRE 14A Preliminary proxy statement Apr 15, 2025 May 23, 2025
8-K Current report
Listing notice
Apr 4, 2025 Apr 3, 2025
EFFECT Filing Apr 1, 2025 —
8-K Current report
Material agreement
Mar 28, 2025 Mar 28, 2025
CORRESP Letter to the SEC Mar 28, 2025 —
S-3 Shelf registration Mar 28, 2025 —
UPLOAD Letter from the SEC Mar 20, 2025 —
DRSLTR Filing Mar 14, 2025 —
DRS Filing Mar 14, 2025 —
S-8 Employee stock plan registration Mar 14, 2025 —
10-K Annual report Mar 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 12, 2025 Mar 12, 2025
8-K Current report
Other events
Feb 24, 2025 Feb 24, 2025
8-K Current report
Other events
Feb 4, 2025 Feb 4, 2025
8-K Current report
Acquisition or sale of assets
Dec 2, 2024 Dec 2, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Nov 4, 2024 Nov 1, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jun 6, 2024 Jun 5, 2024
EFFECT Filing Jun 5, 2024 —
424B3 Prospectus Jun 5, 2024 —
CORRESP Letter to the SEC Jun 3, 2024 —
UPLOAD Letter from the SEC May 31, 2024 —
S-3 Shelf registration May 28, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 5, 2024
8-K Current report
Other events
Apr 17, 2024 Apr 17, 2024
D Filing Mar 19, 2024 —
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Material agreement, Results of operations
Mar 4, 2024 Mar 4, 2024
8-K Current report
Material agreement, Unregistered share sale
Mar 4, 2024 Mar 4, 2024
8-K Current report
Agreement ended, Other events
Feb 16, 2024 Feb 12, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
8-K Current report
Listing notice
Nov 27, 2023 Nov 24, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Agreement ended
Sep 8, 2023 Sep 6, 2023
S-8 Employee stock plan registration Aug 14, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Regulation FD disclosure, Other events
Aug 7, 2023 Aug 7, 2023
8-K Current report
Officer or director change
Jun 23, 2023 Jun 19, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 8, 2023
8-K Current report
Listing notice
Jun 2, 2023 May 26, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
8-K Current report
Agreement ended, Regulation FD disclosure
Apr 27, 2023 Apr 23, 2023
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Apr 17, 2023 Apr 17, 2023
8-K Current report
Officer or director change
Apr 11, 2023 Apr 6, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 11, 2023
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure, Other events
Feb 23, 2023 Feb 23, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Other events
Dec 22, 2022 Dec 16, 2022
8-K Current report
Bylaw or fiscal year change
Dec 16, 2022 Dec 15, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Regulation FD disclosure
Oct 11, 2022 Oct 11, 2022
8-K Current report
Regulation FD disclosure
Oct 7, 2022 Oct 6, 2022
S-8 Employee stock plan registration Aug 5, 2022 —
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 1, 2022 Jun 29, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 8, 2022
8-K Current report
Other events
May 23, 2022 May 19, 2022
10-Q Quarterly report May 6, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Exit or restructuring costs, Impairment
May 2, 2022 Apr 26, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 8, 2022
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Apr 25, 2022 Apr 25, 2022
8-K Current report
Other events
Apr 14, 2022 Apr 14, 2022
8-K Current report
Other events
Mar 14, 2022 Mar 14, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2022 Jan 11, 2022
UPLOAD Letter from the SEC Dec 13, 2021 —
8-K Current report
Officer or director change
Nov 15, 2021 Nov 11, 2021
CORRESP Letter to the SEC Nov 9, 2021 —
10-Q Quarterly report Nov 5, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
UPLOAD Letter from the SEC Oct 26, 2021 —
S-8 Employee stock plan registration Aug 18, 2021 —
10-Q Quarterly report Aug 6, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Shareholder vote results
Jun 15, 2021 Jun 10, 2021
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 10, 2021
S-3ASR Automatic shelf registration Mar 12, 2021 —
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Material agreement
Feb 17, 2021 Feb 12, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Acquisition or sale of assets
Jan 5, 2021 Dec 30, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Dec 22, 2020 Dec 16, 2020
8-K Current report
Bylaw or fiscal year change
Dec 21, 2020 Dec 15, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 2, 2020 Sep 28, 2020
S-8 Employee stock plan registration Aug 7, 2020 —
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results, Other events
Jun 23, 2020 Jun 17, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 17, 2020
8-K Current report
Regulation FD disclosure
Apr 2, 2020 Apr 2, 2020
10-K Annual report Feb 28, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Other events
Jan 15, 2020 Jan 14, 2020
8-K Current report
Results of operations, Other events
Jan 13, 2020 Jan 13, 2020
8-K Current report
Material agreement
Jan 10, 2020 Jan 9, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 17, 2019 Dec 12, 2019
8-K Current report
Other events
Dec 6, 2019 Dec 5, 2019
8-K Current report
Officer or director change
Dec 5, 2019 Dec 2, 2019
8-K Current report
Officer or director change
Nov 19, 2019 Nov 13, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
8-K Current report
Officer or director change
Oct 21, 2019 Oct 15, 2019
8-K Current report
Officer or director change
Oct 1, 2019 Sep 25, 2019
8-K/A Amended current report
Other events
Aug 30, 2019 Jul 23, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Other events
Jul 25, 2019 Jul 23, 2019
8-K Current report
Shareholder vote results
Jun 14, 2019 Jun 12, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
May 3, 2019 Apr 29, 2019
DEFA14A Additional proxy material Apr 30, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 12, 2019
8-K Current report
Other events
Mar 1, 2019 Mar 1, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 28, 2019 Feb 28, 2019
8-K Current report
Other events
Feb 15, 2019 Feb 15, 2019
UPLOAD Letter from the SEC Feb 8, 2019 —
8-K Current report
Bylaw or fiscal year change, Other events
Feb 6, 2019 Feb 4, 2019
8-K Current report
Results of operations, Other events
Jan 8, 2019 Jan 8, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NKTR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
906709
Former names
INHALE THERAPEUTIC SYSTEMS INC (until Jan 10, 2003); INHALE THERAPEUTIC SYSTEMS (until May 14, 1998)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.